A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas.
about
Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zetaSolution structure of midkine, a new heparin-binding growth factorSerum midkine levels are increased in patients with various types of carcinomasStructure and function of midkine as the basis of its pharmacological effectsInvolvement of midkine in neuroblastoma tumourigenesisInhibition of the growth factor MDK/midkine by a novel small molecule compound to treat non-small cell lung cancerMidkine is a NF-kappaB-inducible gene that supports prostate cancer cell survival.A novel small-molecule compound diaporine A inhibits non-small cell lung cancer growth by regulating miR-99a/mTOR signaling.Enhanced therapeutic effects of combined chemotherapeutic drugs and midkine antisense oligonucleotides for hepatocellular carcinomaComplete regression of human malignant mesothelioma xenografts following local injection of midkine promoter-driven oncolytic adenovirusNuclear targeting by the growth factor midkine.Premature ligand-receptor interaction during biosynthesis limits the production of growth factor midkine and its receptor LDL receptor-related protein 1Growth factor midkine is involved in the pathogenesis of diabetic nephropathy.Midkine: a promising molecule for drug development to treat diseases of the central nervous systemA rodent model for Wilms tumors: embryonal kidney neoplasms induced by N-nitroso-N'-methylurea.miR-1289 and "Zipcode"-like Sequence Enrich mRNAs in MicrovesiclesPediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children.Truncated midkine as a marker of diagnosis and detection of nodal metastases in gastrointestinal carcinomas.Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases.The advances of Midkine with peripheral invasion in pancreatic cancer.Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelinNucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vesselsA dominant-negative pleiotrophin mutant introduced by homologous recombination leads to germ-cell apoptosis in male mice.Clinical significance of midkine expression in pancreatic head carcinoma.Midkine as a prognostic biomarker in oral squamous cell carcinoma.Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer.Midkine: A Novel Biomarker to Predict Malignancy in Patients with Nodular Thyroid Disease.Midkine translocated to nucleoli and involved in carcinogenesis.Experimental animal models of pancreatic carcinogenesis for prevention studies and their relevance to human disease.In vitro and in vivo suppression of hepatocellular carcinoma growth by midkine-antisense oligonucleotide-loaded nanoparticlesMidkine: a novel prognostic biomarker for cancer.PKCδ/midkine pathway drives hypoxia-induced proliferation and differentiation of human lung epithelial cells.Midkine is a serum and urinary biomarker for the detection and prognosis of non-small cell lung cancer.Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.Proteomic profiling of retinoblastoma by high resolution mass spectrometry.Promotion of self-renewal of embryonic stem cells by midkineMidkine induces the transformation of NIH3T3 cells.Midkine and pleiotrophin have bactericidal properties: preserved antibacterial activity in a family of heparin-binding growth factors during evolution.Midkine concentrations in fine-needle aspiration of benign and malignant thyroid nodules.Involvement of midkine in the development of pulmonary fibrosis.
P2860
Q22253290-6953570B-9E2B-4A0B-BC75-5117F41224D6Q24310244-CCF07433-7CF2-486E-88CE-C6009E54E9A3Q24649020-4AF73AF3-B400-4DAC-8E34-97F8C2F599B9Q27013798-92E02493-35FE-4801-8392-38C4FA4EF697Q27026748-0B5DA8D8-0674-4BEB-93FD-84FC2627908DQ28535406-4F7B2A0C-C819-414C-8E41-F482AF5A88A7Q33319901-EA13A824-E3B5-4715-9D7F-AE6F5BA4209AQ34036145-B44A94E5-75A9-4838-8C5E-DA0003F45723Q34099481-FEAEB771-1179-4EAA-9D3F-A676905553E2Q34124614-96A44D55-FAE9-4529-924E-256CD18D3A3BQ34286252-677E9BCC-7DA4-4CD8-892E-AE1003AC7B98Q34624412-3D2798D5-AB9C-4297-93E8-C856496DC5C8Q35070717-528A71C5-5F18-436F-B0F5-83EA0DF37D33Q35701268-036904CA-AB52-4060-9116-E0B0A363F97DQ35823348-A4741F5C-D6E7-4A7F-8686-B1E0D3DF19C6Q36053822-B7F1F0AC-AD62-4340-AFD2-862C100D7A1FQ36109700-A57873E6-4022-4AF1-A14B-C69168F7B378Q36115346-1422937D-4762-42AF-AFE7-EC40B87F209AQ36160231-DDE10E96-466E-4BE8-B6C9-252AD4EFF99CQ36250696-B1DD36AB-87E2-4232-A491-50061F0F5AA5Q36320997-67B2F665-F7E1-4710-9F6C-C2D6186C5504Q36324866-E383D476-561C-42B8-84E6-B74545F88125Q36379510-01C7B832-6523-426E-920C-9C830AD9E36DQ36610901-8E82288B-318C-498B-BCF5-C5AB0A0C7C88Q36858230-56E02BE7-7857-48AD-8747-02E0C808E5F6Q36862380-0E2396C7-DDC4-459D-9E00-C5BF79693F9FQ37092811-9BCB2620-A744-4D1A-A912-92DF8BBAAA8AQ37122317-4B58B2DA-D7FF-4B33-9FE4-A934FFAB086EQ37129801-33CD441F-F4A2-4C68-A7EC-C709510D18E2Q37174057-6D83ACD6-AFB0-45CC-A571-0B71BE17FCB6Q37328317-E1667EA8-FF82-468B-B67A-0E563FF4E642Q37655955-95574AE7-66CB-45C9-8DDE-8797911C1CF0Q37699449-7A702021-8EAA-4F8A-B4D6-46815662700EQ38181600-C6FB9D69-04F4-4256-9345-C4EDDC0F2FB3Q38734623-C86558E0-D199-4830-88FD-10F08D1CA69AQ39018408-87B6CB95-050A-46A3-98C8-20068271FFD5Q39715103-77F1A5E2-DE13-4C25-8C72-68D65DB4FBCAQ40602871-C1DB67B3-DD21-4CE8-BAD2-5C5F83123EF8Q41164512-13548145-AB96-457A-ABB1-9BEF3A22252EQ41600076-5FC191B1-D96A-44D0-A22D-D3351DB7719B
P2860
A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
A new family of heparin-bindin ...... or and other human carcinomas.
@ast
A new family of heparin-bindin ...... or and other human carcinomas.
@en
type
label
A new family of heparin-bindin ...... or and other human carcinomas.
@ast
A new family of heparin-bindin ...... or and other human carcinomas.
@en
prefLabel
A new family of heparin-bindin ...... or and other human carcinomas.
@ast
A new family of heparin-bindin ...... or and other human carcinomas.
@en
P2093
P1433
P1476
A new family of heparin-bindin ...... mor and other human carcinomas
@en
P2093
Hamanoue M
Kadomatsu K
Matsubara S
Muramatsu T
Nakagawara A
P304
P407
P577
1993-03-01T00:00:00Z